COMERICA BANK - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMERICA BANK ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q4 2022$325
-99.9%
24,661
-24.1%
0.00%
-40.0%
Q3 2022$598,000
-48.5%
32,496
-10.9%
0.01%
-50.0%
Q2 2022$1,162,000
-27.3%
36,451
-6.6%
0.01%
-16.7%
Q1 2022$1,598,000
-14.8%
39,017
-3.4%
0.01%
-14.3%
Q4 2021$1,876,000
+71.2%
40,402
+83.8%
0.01%
+100.0%
Q3 2021$1,096,000
-29.1%
21,983
-13.2%
0.01%
-22.2%
Q2 2021$1,546,000
-4.0%
25,323
-2.6%
0.01%
-10.0%
Q1 2021$1,610,000
-45.1%
25,999
-5.1%
0.01%
-47.4%
Q4 2020$2,935,000
+1.4%
27,394
-9.0%
0.02%
-9.5%
Q3 2020$2,894,000
-38.5%
30,114
-39.9%
0.02%
-41.7%
Q2 2020$4,705,000
+40.7%
50,070
+9.7%
0.04%
+16.1%
Q1 2020$3,344,000
+44.1%
45,626
+8.5%
0.03%
+72.2%
Q4 2019$2,320,000
+2.6%
42,045
+0.7%
0.02%0.0%
Q3 2019$2,261,000
+23.1%
41,757
-3.6%
0.02%
+20.0%
Q2 2019$1,837,000
-49.5%
43,323
-36.3%
0.02%
-48.3%
Q1 2019$3,635,000
-7.5%
68,018
+3.9%
0.03%
-12.1%
Q4 2018$3,930,000
-1.3%
65,494
-0.5%
0.03%
+3.1%
Q3 2018$3,981,000
+11.9%
65,807
+0.7%
0.03%
+28.0%
Q2 2018$3,558,000
-0.3%
65,361
-0.4%
0.02%0.0%
Q1 2018$3,567,000
-24.1%
65,614
-29.6%
0.02%
-19.4%
Q4 2017$4,701,000
+58.1%
93,137
+28.5%
0.03%
+40.9%
Q3 2017$2,973,000
+72.6%
72,497
+51.3%
0.02%
+69.2%
Q2 2017$1,722,000
-8.0%
47,910
-22.4%
0.01%
-7.1%
Q1 2017$1,871,000
+0.2%
61,721
+1.3%
0.01%
-6.7%
Q4 2016$1,868,000
-3.0%
60,921
+0.9%
0.02%
-11.8%
Q3 2016$1,926,000
+14.5%
60,386
+6.4%
0.02%
+13.3%
Q2 2016$1,682,000
-5.1%
56,770
+26.8%
0.02%
-6.2%
Q1 2016$1,773,000
-6.3%
44,779
-16.6%
0.02%
-15.8%
Q4 2015$1,892,000
-2.2%
53,663
-21.0%
0.02%
+5.6%
Q3 2015$1,935,000
-62.0%
67,918
-56.1%
0.02%
-18.2%
Q2 2015$5,092,000
+127.5%
154,554
+98.6%
0.02%
+15.8%
Q1 2015$2,238,000
-47.2%
77,831
-50.0%
0.02%
+5.6%
Q4 2014$4,238,000
+191.1%
155,664
+127.9%
0.02%
+38.5%
Q3 2014$1,456,000
+115.1%
68,318
+126.6%
0.01%
+116.7%
Q2 2014$677,000
-11.3%
30,143
-0.2%
0.01%0.0%
Q1 2014$763,000
+7.5%
30,208
-2.2%
0.01%0.0%
Q4 2013$710,000
+7.9%
30,898
-10.5%
0.01%
+20.0%
Q3 2013$658,000
+55.6%
34,537
+17.5%
0.01%
+66.7%
Q2 2013$423,00029,3850.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders